Building access to the Regenstrief Institute is currently restricted. More on our coronavirus precautions.
See our coronavirus precautions.

A Regenstrief Institute and Indiana Clinical and Translational Sciences Institute (CTSI) conference on the use of artificial intelligence (AI) in healthcare created a discussion about monitoring the impact of algorithms on care.

During the second day of the conference, Regenstrief President and Chief Executive Officer Peter Embí, M.D., M.S., made a case for “algorithmovigilance,” which is the systematic monitoring of healthcare algorithms to develop and respond to expected and unexpected effects. He stated he believes this surveillance is necessary to address and correct data biases as well as better understand the generalizability of algorithms.

The panel discussion was the subject of a Healthcare Innovation article.

Read the article

In addition to monitoring the impact of AI, the three-day conference, Artificial Intelligence: Applying Research and Engineering Solutions for Emergent Needs in Healthcare, covered the application of AI in healthcare settings, the necessary building blocks to create effective AI and the future applications of this technology.

More than 500 people from 16 countries signed up to attend.

Related Influence

Jul 07, 2021 • Influence
Algorithm developed by Regenstrief/Merck collaboration hailed as promising research tool
A natural language processing (NLP) algorithm to identify patients with chronic cough, created and validated by Regenstrief Institute, Indiana University and Merck & Co. research scientists, is being recognized for its ingenuity and its potential.   The paper describing the algorithm’s development, Identifying and Characterizing a Chronic Cough Cohort Through Electronic Health Records, was published in the June 2021 edition of Chest Journal, along with an editorial written…
Continue Reading >
Jun 22, 2021 • Influence
Regenstrief experts share cancer-related research as part of IU Simon Cancer Center Series
Two Regenstrief research scientists who focus on cancer research are sharing their knowledge in the Indiana University Melvin and Bren Simon Comprehensive Cancer Center’s monthly series called “Simon Says.”  The monthly virtual series was created to better connect cancer experts with the community, giving people the opportunity to hear about the latest research and ask questions.   [caption…
Continue Reading >